News
News release
-
The roots of UTC track back to UPenn, where our ...
ZHAO Yangbing was the director of T cell engineering lab, and co-founder Prof. LIU Xiaojun the deputy director. A pioneer in T cell therapy
Details -
Apart from involving in collab-oration with Novartis on the...
Is a bio-tech providing next-generation T-cell therapy to overcome TME challenges and it has raised over 200 million dollar from investors since
Details -
Founded in Octber of 2019 in Shanghai by ZHAO Yangbing
LIU Xiaojun, and SONG Xiaodong, an ex-Pfizer and ex-J&J executive, UTC therapeutics is a pre-clinical biotech focusing on adoptive
Details -
The roots of UTC track back to UPenn, where our ...
ZHAO Yangbing was the director of T cell engineering lab, and co-founder Prof. LIU Xiaojun the deputy director. A pioneer in T cell therapy
Details -
Apart from involving in collab-oration with Novartis on the...
Is a bio-tech providing next-generation T-cell therapy to overcome TME challenges and it has raised over 200 million dollar from investors since
Details -
Founded in Octber of 2019 in Shanghai by ZHAO Yangbing
LIU Xiaojun, and SONG Xiaodong, an ex-Pfizer and ex-J&J executive, UTC therapeutics is a pre-clinical biotech focusing on adoptive
Details
